Navigation Links
Latest research on allergies: Specific immunotherapy can help
Date:6/11/2008

The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies.

When it is green and the flowers have returned, the allergy season has hit its peak. And the number of people affected is still rising. At least 1 in 5 people in get hayfever, and up to half of the population react at least sometimes to airborne allergens like pollen or house dust mites. But we still do not why allergies increased so much in recent decades. The Director of the Institute, Professor Peter Sawicki, said today that none of the theories about the increase in allergies has been proven. For example, childhood immunisation does not seem to be responsible for the growth of allergies.

"There are many unproven claims about allergies, said Professor Sawicki, "but there is also a growing body of research that has sifted out some facts from the myths. For example, expensive and time-consuming effort like removing all carpets from the house or washing bedlinen very frequently will be a waste for most people: it really is not possible to remove all the allergens from the house, no matter how hard you try. But there are things that can work, like specific immune therapy. And a range of drugs can reduce symptoms."

The Institute has reviewed the latest independent analyses of allergy research to find out which treatments or prevention measures could really work. Allergen immunotherapy can done by injections or sublingual ("under the tongue") drops, tablets or sprays. Both injections and sublingual treatments work. A report* shows that more than a dozen of these immunotherapy extracts are now amongst the 3,000 most prescribed medicines in Germany.

According to Professor Sawicki, "Sublingual therapy in particular is becoming very popular in Europe. Research has shown that it can reduce allergic symptoms
'/>"/>

Contact: Hilda Bastian
information@iqwig.de
49-221-356-850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
2. Scientists, physicians present latest findings in personalized cancer treatment and prevention
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Health psychologists discuss latest research findings
5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
6. PA Governor Rendell Announces Latest Nominations and Appointments
7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
9. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
11. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Diehard soccer fans will definitely want ... the game between Manchester City and Chelsea FC ... These two teams are highly decorated in the English ... A-game to the Busch Stadium, home of the St. Louis ... first time that a professional sporting event and non-baseball game ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... some of the changes brought about by the disorder ... New research has found that people with diabetes who ... risk of having a severe low blood sugar (hypoglycemia) ... people with diabetes who aren,t depressed. "Depression ...
(Date:5/21/2013)... has awarded New York University neuroscientist J. Anthony Movshon ... his "pioneering work on the neuroscience of vision." ... Neural Science, is the second NYU neuroscience professor to ... the honor in 2011 in recognition of his "seminal ... fear learning, and fear memory." , Movshon, a ...
(Date:5/21/2013)... OK (PRWEB) May 21, 2013 Representatives with ... been such a success that the company has achieved its ... plan from day one was to move Hammerhead Bicycles from ... Spokesman and President Scott Robertson. , Robertson explained that the ... and continue to exclusively focus on all things 29er and ...
(Date:5/21/2013)... COLUMBUS, OHIO, MAY 21, 2013 Three major Ohio ... of Dimes Foundation to establish a new collaborative research ... premature birth. The March of Dimes intends to invest ... , "The March of Dimes Prematurity Research Center -- ... Jennifer L. Howse, President of the March of Dimes. ...
Breaking Medicine News(10 mins):Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:NYU's Movshon receives Lashley Award for his research on the neuroscience of vision 2Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3
... Associates, LLC,announced today that it has issued an ... Board: BOCX). The full 52-page,report can be found ... or "the Company") is a biotechnology company,developing products ... global oncology market forecast to reach over $50 ...
... Establishes Effects of Puzzle ... and Word Games on the Human Body and Mind, ... Carolina,University,s Department of Recreation and Leisure Studies today revealed,the ... measured,the stress-relieving and other mood-lifting effects of so-called "casual",video ...
... of the major side effects of pain therapy for ... Food and Drug Administration on April 24, 2008, for ... patients receiving palliative care for advanced illness such as ... for Medicinal Products for Human Use, also rendered a ...
... Company -, LAVAL, QC, April 28 /PRNewswire-FirstCall/ ... that Claire Brulle, M.D. has been appointed,Senior Vice-President ... Medical Officer Dr. Sylvie Bouchard has retired from ... "Dr. Brulle brings to Labopharm a proven ...
... 1,440 Stores in May 2008, NEW YORK ... medical,device company publicly traded on the Tel Aviv ... hypertension treatment device,clinically-proven to significantly lower blood pressure, ... Kingdom this May through,Lloyds Pharmacy, the leading community ...
... 28 Readers in Europe and other parts of,the ... debut book,from London-born author Shireen Jeejeebhoy. It tells the ... medical history as the first,person to live long-term strictly ... has just scooped awards in the US for Editor,s ...
Cached Medicine News:Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7Health News:Drug developed at the University of Chicago wins FDA approval 2Health News:Drug developed at the University of Chicago wins FDA approval 3Health News:Drug developed at the University of Chicago wins FDA approval 4Health News:Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer 2Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 2Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 3Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 4Health News:Story of Woman's Courage and Medical Innovation Top Choice for Readers 2
(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... ), a specialty pharmaceutical company focused on ... for the treatment of acute and breakthrough ... in a placebo-controlled Phase 3 study of ... analgesia) System (NanoTab System), the primary efficacy ...
(Date:5/20/2013)... May 21, 2013   ... world,s health ministers gather to address the large physical ... and neurological disorders (MNDs) affect 700 million people annually ... (NCD) burden ,Do You Mind?, helps patients, ... each can play to collectively address MNDs , ...
(Date:5/20/2013)... MINNEAPOLIS , May 20, 2013  Uroplasty, Inc. ... will release financial results for the fiscal fourth quarter ... market close on Thursday, May 30, 2013. The Company ... these results on Thursday, May 30, 2013 at 4:30 ... to participate in the conference call should dial 888-549-7750, ...
Breaking Medicine Technology:Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 2
... For maximum productivity, and proven ... a compact, fully automatic cell washing ... a fast 80-second wash cycle for ... touch controls, and standardized, reproducible procedures. ...
Excellent all-around performance in digital format - MIC-D offers an exciting new way to observe the natural world. Multiple performance features provide new ways to enjoy microscope observation....
... refrigerated floor model centrifuge. High throughput, ... full speed with all windshield rotors, ... collected at a remote personal computer ... include automatic imbalance detection and shut ...
... low speed refrigerated centrifuge. Instant rotor ... patented system, comprehensive control using VIDEOset ... individual password protection of programs, 10 ... run profiles), powerful refrigeration 4C or ...
Medicine Products: